These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection. Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859 [TBL] [Abstract][Full Text] [Related]
9. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Fife KH; Warren TJ; Justus SE; Heitman CK; Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016 [TBL] [Abstract][Full Text] [Related]
10. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life. Handsfield HH; Warren T; Werner M; Phillips JA Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847 [TBL] [Abstract][Full Text] [Related]
11. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M; N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423 [TBL] [Abstract][Full Text] [Related]
12. Valacyclovir. New indication: for genital herpes, simpler administration. Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269 [TBL] [Abstract][Full Text] [Related]
13. [Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment]. Bossi P Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):477-93. PubMed ID: 12122319 [TBL] [Abstract][Full Text] [Related]
14. Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman. Elfering L; van der Sluis WB; Mermans JF; Buncamper ME Int J STD AIDS; 2017 Jul; 28(8):841-843. PubMed ID: 28632111 [TBL] [Abstract][Full Text] [Related]
15. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673 [TBL] [Abstract][Full Text] [Related]
16. Recent developments in the management of herpes simplex virus infection in HIV-infected persons. Bartlett JG Clin Infect Dis; 2004 Nov; 39 Suppl 5():S237-9. PubMed ID: 15494894 [No Abstract] [Full Text] [Related]
18. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial. Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557 [TBL] [Abstract][Full Text] [Related]
19. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071 [TBL] [Abstract][Full Text] [Related]